cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Wave Life Sciences Ltd
3 own
11 watching
Current Price
$5.51
$0.2
(3.77%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
558.95M
52-Week High
52-Week High
7.12000
52-Week Low
52-Week Low
3.15000
Average Volume
Average Volume
0.59M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization558.95M
icon52-Week High7.12000
icon52-Week Low3.15000
iconAverage Volume0.59M
iconDividend Yield--
iconP/E Ratio--
What does the Wave Life Sciences Ltd do?
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional proteins, or modulate protein expression. The company also develops WVE-004, a C9orf72 molecule for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia; WVE-003, a mutant huntingtin SNP3 molecule for the treatment of Huntington s disease; WVE-N531, an Exon 53 molecule for the treatment of Duchenne muscular dystrophy; and ATXN3, a discovery stage program for the treatment of spinocerebellar ataxia 3, as well as multiple preclinical programs for CNS disorders. In addition, it focuses on developing GalNAc-conjugated AIMers to treat hepatic indications comprising Alpha-1 antitrypsin deficiency (AATD); and two preclinical programs, such as Usher syndrome type 2A (USH2A) and retinitis pigmentosa due to a P23H mutation in the RHO gene (RhoP23H) for the treatment of retinal diseases. It has collaboration agreements with Pfizer Inc., Takeda Pharmaceutical Company Limited, University of Oxford, University of Massachusetts, Western Washington University, Grenoble Institute of Neurosciences, IRBM S.p.A, University of Louisville, and University College London. The company was incorporated in 2012 and is based in Singapore.
Read More
How much money does Wave Life Sciences Ltd make?
News & Events about Wave Life Sciences Ltd.
Globe Newswire
5 months ago
CAMBRIDGE, Mass., June 26, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases, today announced that the company has been added to the small-cap Russell 2000 ...
Benzinga
5 months ago
Latest Ratings for WVE DateFirmActionFromTo Mar 2021SVB LeerinkReiteratesMarket Perform Dec 2020HC Wainwright & Co.AssumesBuy Oct 2020RBC CapitalInitiates Coverage OnSector Perform View More Analyst Ratings for WVE View the Latest Analyst Ratings read more...
Globe Newswire
9 months ago
CAMBRIDGE, Mass., March 02, 2023 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that management will host a live webcast and conference ...
Globe Newswire
11 months ago
53% mean exon skipping and PN chemistry improved pharmacology of WVE-N531 compared with Waves first-generation DMD program demonstrated high muscle concentrations with a mean of 42 micrograms/gram WVE-N531 appeared safe and well tolerated Third Wave clinical trial evaluating a PN chemistry-...
Globe Newswire
1 year ago
CAMBRIDGE, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive ...
Frequently Asked Questions
Frequently Asked Questions
What is Wave Life Sciences Ltd share price today?
plus_minus_icon
Can Indians buy Wave Life Sciences Ltd shares?
plus_minus_icon
How can I buy Wave Life Sciences Ltd shares from India?
plus_minus_icon
Can Fractional shares of Wave Life Sciences Ltd be purchased?
plus_minus_icon
What are the documents required to start investing in Wave Life Sciences Ltd stocks?
plus_minus_icon
What is today’s traded volume of Wave Life Sciences Ltd?
plus_minus_icon
What is today’s market capitalisation of Wave Life Sciences Ltd?
plus_minus_icon
What is the 52-Week High and Low Range of Wave Life Sciences Ltd?
plus_minus_icon
What percentage is Wave Life Sciences Ltd down from its 52-Week High?
plus_minus_icon
What percentage is Wave Life Sciences Ltd up from its 52-Week Low?
plus_minus_icon
Current Price
$5.51
$0.2
(3.77%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Seres Therapeutics Inc
Seres Therapeutics Inc
$1.07
$0.03 (2.88 %)
Collegium Pharmaceutical Inc
Collegium Pharmaceutical Inc
$25.60
$-0.03 (-0.12 %)
Phibro Animal Health Corp
Phibro Animal Health Corp
$9.87
$0.28 (2.92 %)
Revance Therapeutics Inc
Revance Therapeutics Inc
$7.24
$0.47 (6.94 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Seres Therapeutics Inc
Seres Therapeutics Inc
$1.07
$0.03 (2.88 %)
Collegium Pharmaceutical Inc
Collegium Pharmaceutical Inc
$25.60
$-0.03 (-0.12 %)
Phibro Animal Health Corp
Phibro Animal Health Corp
$9.87
$0.28 (2.92 %)
Revance Therapeutics Inc
Revance Therapeutics Inc
$7.24
$0.47 (6.94 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Foreside Fund Services acts as the distributor to the DriveWealth ICE 100 Index ETF and is not affiliated with Borderless Investing Inc, DriveWealth LLC, BlackOak Investors LP, ACR Group, or other entities referenced on this website.

              Get Started with as little as $1.00